| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 152.53B | 150.00B | 148.61B | 140.75B | 133.99B | 122.65B |
| Gross Profit | 17.37B | 17.60B | 17.26B | 15.98B | 14.78B | 13.74B |
| EBITDA | 3.21B | 3.42B | 5.90B | 2.90B | 2.62B | 2.61B |
| Net Income | 3.61B | 3.61B | 3.58B | 3.36B | 3.16B | 3.08B |
Balance Sheet | ||||||
| Total Assets | 138.25B | 136.62B | 121.79B | 110.26B | 100.03B | 94.49B |
| Cash, Cash Equivalents and Short-Term Investments | 14.24B | 25.94B | 29.58B | 24.54B | 26.89B | 24.11B |
| Total Debt | 2.03B | 2.03B | 2.38B | 2.46B | 2.38B | 1.87B |
| Total Liabilities | 90.60B | 90.00B | 78.12B | 68.64B | 60.42B | 57.30B |
| Stockholders Equity | 46.46B | 45.44B | 42.58B | 40.36B | 38.41B | 36.72B |
Cash Flow | ||||||
| Free Cash Flow | 7.77B | 5.14B | 4.14B | 3.68B | 2.74B | 1.92B |
| Operating Cash Flow | 8.63B | 6.22B | 5.36B | 4.91B | 4.51B | 5.45B |
| Investing Cash Flow | -711.27M | -7.17B | -2.12B | -2.29B | -3.67B | -2.24B |
| Financing Cash Flow | -2.08B | -2.34B | -2.40B | -1.74B | -628.35M | -1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$176.35B | 16.02 | 5.60% | 4.03% | 3.24% | 8.66% | |
69 Neutral | HK$28.19B | 3.15 | 7.86% | 5.24% | 1.54% | -2.09% | |
68 Neutral | HK$570.80B | 13.70 | 7.19% | 5.40% | 0.53% | 5.28% | |
65 Neutral | HK$10.14B | 9.94 | 8.45% | 7.46% | -0.62% | -5.10% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | HK$93.19B | 16.50 | 14.46% | 2.86% | 2.33% | 2.41% | |
49 Neutral | HK$45.60B | -1,547.01 | -2.39% | 1.68% | 4.26% | 36.68% |